Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 17 Mar 2022

Number 2 Feibi Recipe Inhibits H2O2-Mediated Oxidative Stress Damage of Alveolar Epithelial Cells by Regulating the Balance of Mitophagy/Apoptosis

in Respiratory Pharmacology

Xiaofeng Gu
Qi Long
Wan Wei
Jiahuan Tong
Zhipeng Li
Zhengju Zhang
Yang Jiao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.830554

3,860 views
11 citations

Review

Published on 17 Mar 2022

Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis

in Respiratory Pharmacology

Suh-Young Lee
Chang-Min Lee
Bing Ma
Suchitra Kamle
Jack A. Elias
Yang Zhou
Chun Geun Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2022.826471

8,149 views
12 citations

Original Research

Published on 14 Mar 2022

Mitochondrial Protein Akap1 Deletion Exacerbates Endoplasmic Reticulum Stress in Mice Exposed to Hyperoxia

in Respiratory Pharmacology

Sahebgowda Sidramagowda Patil
Ramani Soundararajan
Jutaro Fukumoto
Mason Breitzig
Helena Hernández-Cuervo
Matthew Alleyn
Muling Lin
Venkata Ramireddy Narala
Richard Lockey
Narasaiah Kolliputi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.762840

3,109 views
6 citations

Original Research

Published on 14 Mar 2022

Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway

in Respiratory Pharmacology

Zhen Li
Jing Geng
Bingbing Xie
Jiarui He
Jing Wang
Liang Peng
Yinan Hu
Huaping Dai
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.834604

4,207 views
10 citations

Mini Review

Published on 10 Mar 2022

Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis

in Respiratory Pharmacology

Yasuhiko Koga
Haruka Aoki-Saito
Yosuke Kamide
Makiko Sato
Hiroaki Tsurumaki
Masakiyo Yatomi
Tamotsu Ishizuka
Takeshi Hisada

Frontiers in Pharmacology

doi 10.3389/fphar.2022.865318

7,268 views
20 citations

Review

Published on 10 Mar 2022

Omalizumab and IgE in the Control of Severe Allergic Asthma

in Respiratory Pharmacology

Yasuhiro Gon
Shuichiro Maruoka
Kenji Mizumura

Frontiers in Pharmacology

doi 10.3389/fphar.2022.839011

12,096 views
26 citations

Original Research

Published on 09 Mar 2022

Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway

in Respiratory Pharmacology

Xingxing Hu
Menglin Zou
Lan Ni
Mingyang Zhang
Weishuai Zheng
Bing Liu
Zhenshun Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.829673

7,187 views
20 citations

Original Research

Published on 09 Mar 2022

ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation

in Respiratory Pharmacology

Dongxin Chen
Huirong Tang
Hongchao Jiang
Lei Sun
Wenjuan Zhao
Feng Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2022.835979

4,813 views
11 citations

Review

Published on 08 Mar 2022

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets

in Respiratory Pharmacology

Corrado Pelaia
Enrico Heffler
Claudia Crimi
Angelantonio Maglio
Alessandro Vatrella
Girolamo Pelaia
Giorgio Walter Canonica

Frontiers in Pharmacology

doi 10.3389/fphar.2022.851940

15,128 views
84 citations

Review

Published on 04 Mar 2022

Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review

in Respiratory Pharmacology

Laura Bergantini
Alessandro Mainardi
Miriana d’Alessandro
Paolo Cameli
David Bennett
Elena Bargagli
Piersante Sestini

Frontiers in Pharmacology

doi 10.3389/fphar.2022.748931

5,910 views
36 citations

Original Research

Published on 22 Feb 2022

Screening and Verification of Differentially Expressed Long Non-coding RNAs in the Peripheral Blood of Patients With asthma

in Respiratory Pharmacology

Cheng Ma
Shiyuan Wang
Yuxue Cao
Weifeng Tang
Tulake Wuniqiemu
Fangzhou Teng
Xueyi Zhu
Ying Wei
Jingcheng Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.834009

2,160 views
8 citations

Original Research

Published on 22 Feb 2022

House Dust Mite Aeroallergen Suppresses Leukocyte Phagocytosis and Netosis Initiated by Pneumococcal Lung Infection

in Respiratory Pharmacology

Angelica Papanicolaou
Hao Wang
Jonathan McQualter
Christian Aloe
Stavros Selemidis
Catherine Satzke
Ross Vlahos
Steven Bozinovski

Frontiers in Pharmacology

doi 10.3389/fphar.2022.835848

3,529 views
2 citations

Original Research

Published on 11 Feb 2022

Avasimibe Alleviates Disruption of the Airway Epithelial Barrier by Suppressing the Wnt/β-Catenin Signaling Pathway

in Respiratory Pharmacology

Zicong Zhou
Shixiu Liang
Zili Zhou
Jieyi Liu
Xiaojing Meng
Fei Zou
Changhui Yu
Shaoxi Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2022.795934

4,391 views
4 citations

Original Research

Published on 11 Feb 2022

Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology Strategy

in Respiratory Pharmacology

De-wei Zhu
Qun Yu
Mei-fang Jiang
Dan-dan Wang
Yun-hui Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.825667

5,059 views
5 citations

Original Research

Published on 09 Feb 2022

Systemic Administration of Tempol, a Superoxide Dismutase Mimetic, Augments Upper Airway Muscle Activity in Obese Zucker Rats

in Respiratory Pharmacology

Santhosh M. Baby
Lisa H. Tanner
Joseph F. Discala
Ryan B. Gruber
Yee-Hsee Hsieh
Stephen J. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2022.814032

2,215 views
1 citation

Review

Published on 31 Jan 2022

Challenges for Clinical Drug Development in Pulmonary Fibrosis

in Respiratory Pharmacology

Eric S. White
Matthew Thomas
Susanne Stowasser
Kay Tetzlaff

Frontiers in Pharmacology

doi 10.3389/fphar.2022.823085

18,747 views
34 citations